Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
147.61
-2.39 (-1.59%)
Jul 25, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Genetic Medicines
290.52M
Log In
Genetic Medicines Growth
473.02%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
290.52M
Log In
United States Growth
473.02%
Log In